Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × INDUSTRY × Endocrine × Clear all

Status

Completed 134 Recruiting 43 Terminated 31 Active not recruiting 27 Unknown 14 Withdrawn 5 Not yet recruiting 5 Approved for marketing 4 Enrolling by invitation 2 Suspended 1 No longer available 1 Available 1

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Lymphoid 13 Genitourinary 9 Other hematologic neoplasm 8 Sarcoma 7 Tumor-Agnostic 6 Thoracic 6 Plasma cell 6 Gastrointestinal 6 Myeloid 5 CNS 5 Gynecologic 4 Dermatologic 4 Breast 3 Other solid neoplasm 2 Head & Neck 1 Endocrine 1

Conditions

Pheochromocytoma 1 Paraganglioma 1 Neuroblastoma 1

Interventions

3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01590680 2023-02-28

Expanded Access Protocol Using 131I-MIBG

Jubilant DraxImage Inc.

Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡